wire

« BACK

Pharmacology



Results 1 - 50 of 299.
1 2 3 4 5 6 Next »


Health - Pharmacology - 19.01.2021
RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.

Health - Pharmacology - 18.01.2021
Birmingham maternity experts call for urgent action on pregnancy ’drug drought’
Leaders in maternal healthcare have called for lifesaving research into pharmaceuticals for use during pregnancy in a new report highlighting the challenges of pregnancy-related complications, pre-term birth and pre-existing conditions.

Health - Pharmacology - 08.01.2021
Welsh ’wellness’ tea arrives in lockdown
The first batch of a new wellness green tea blended with pure Welsh honey and scientifically identified botanicals has arrived in Wales.

Health - Pharmacology - 06.01.2021
Global experts urge everyone to talk about COVID-19 vaccines responsibly
A team of renowned scientific experts has joined forces from across the world to help fight the spread of misinformation about the COVID-19 vaccines, which hold the key to beating the deadly pandemic and releasing countries from debilitating lockdown restrictions.

Health - Pharmacology - 06.01.2021
LifeArc funds COVID-19 drug screening hub at the University of Glasgow
A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR).

Pharmacology - Health - 17.12.2020
Opinion: Coronavirus vaccines - how will we know when life can go back to normal?
The first people have begun to receive vaccines as part of mass vaccination campaigns to immunise people against Covid-19. Excitement is building - finally, the end of the coronavirus crisis is in sight, writes Dr Jasmina Panovska-Griffiths (UCL Epidemiology & Health). Since early December, elderly patients and health workers in 50 hospitals across the UK have been given the vaccine developed by Pfizer and BioNTech.

Health - Pharmacology - 16.12.2020
AI could help cut waiting times for cancer by automating mark-up of patient scans prior to radiotherapy
Doctors at Addenbrooke's Hospital in Cambridge aim to drastically cut cancer waiting times by using artificial intelligence (AI) to automate lengthy radiotherapy preparations.

Health - Pharmacology - 16.12.2020
New Scottish study to "REACH" people with heart failure at home
REACH-HF - is an award winning cardiac rehabilitation programme which helps people living with heart failure improve their quality of life from the comfort and safety of their own homes - is being rolled out in six NHS Scotland Health Boards from this month.

Health - Pharmacology - 15.12.2020
Vaccines must prevent infection, disease progression and transmission - in every country - to truly bring COVID-19 under control
An editorial co-authored by a member of the UK's influential SAGE committee that advises the UK Government on COVID-19, and published in Anaesthesia (a journal of the Association of Anaesthetists) sa

Health - Pharmacology - 11.12.2020
No deal Brexit could have detrimental impact for four million people in UK living with a rare disease
Experts have warned that a 'no deal' Brexit will result in the exclusion of the UK from the 24 European Reference Networks (ERNs) that were established to improve the care of patients bearing the lifelong burden of a rare disease, which require highly specialised diagnosis and treatment.

Health - Pharmacology - 04.12.2020
Glasgow at the forefront of paediatric Crohn’s Trials
A pilot Crohn's trial led by doctors at Glasgow's Royal Hospital for Children and scientists at the University of Glasgow has seen remarkable results with 60% of patients entering remission after just eight weeks, giving hope to patients across the country.

Pharmacology - Health - 02.12.2020
Opinion: Designing Vaccines for People, Not Profits
There is still a long way to go to deliver on the promise of a universal, freely available "people's vaccine", argue Professor Mariana Mazzucato, Henry Lishi Li and Els Torreele (All UCL Institute for Innovation & Public Purpose).

Health - Pharmacology - 30.11.2020
COVID-19: Fall in cancer treatment rose following ’rapid’ NHS guidance
The number of patients starting anticancer therapies dropped by more than 30 per cent in April, the month following the UK's first COVID-19 lockdown, but went above pre-pandemic levels within three months, finds a new study of NHS England data co-led by UCL researchers.

Health - Pharmacology - 25.11.2020
Opinion: Should Covid-19 vaccines be mandatory?
To be properly protective, Covid-19 vaccines need to be given to most people worldwide. Here, Dr Vageesh Jain (UCL Institute for Global Health) argues against the need for mandatory vaccines, while Dr Alberto Giubilini argues the reverse.

Health - Pharmacology - 25.11.2020
Re-starting global economy depends on tackling ’last mile’ of vaccine journey
Re-starting the global economy for billions of people will depend on successfully overcoming logistical challenges in the ‘last mile' of a COVID-19 vaccine's journey to immunisation stations, according to a new report.

Health - Pharmacology - 19.11.2020
Bristol secures £45M to advance gene therapy treatment of chronic kidney diseases
The University of Bristol has secured a Ā£45million deal to advance its groundbreaking gene therapy technology for chronic kidney diseases.

Pharmacology - Health - 18.11.2020
New clinical trial launched for early treatment of COVID-19
A potential treatment for COVID-19, which has shown early promise in China and Japan, will be trialled in NHSGGC in colloboration with the University of Glasgow.

Pharmacology - Health - 12.11.2020
UofG scientist set to play leading role in ’first of its kind’ clinical trail to bring hope to people with lung cancer
A University of Glasgow scientist is set to play a leading role in a ground breaking clinical trial for people with lung cancer.

Health - Pharmacology - 11.11.2020
A few kilograms weight loss nearly halves the risk of diabetes, large scale research study finds
Providing support to help people with prediabetes make small changes to their lifestyle, diet and physical activity can almost halve the risk of developing Type 2 diabetes, according the results of the Norfolk Diabetes Prevention Study (NDPS) the largest diabetes prevention research study in the world in the last 30 years.

Health - Pharmacology - 10.11.2020
Oxford ramps up COVID-19 testing capability
The University of Oxford has joined forces with Thermo Fisher Scientific, the world leader in serving science, to ramp up the university's capacity to deliver COVID-19 testing data.   The new rapid testing laboratory and jointly developed Thermo Scientific OmnipathTM Combi SARS-CoV-2 IgG ELISA test detects and quantifies antibodies against the coronavirus and increases the University of Oxford's testing capacity to up to 50,000 tests per day.

Health - Pharmacology - 09.11.2020
Study aims to REACH out to heart failure patients
The Universities of Dundee, Glasgow, Exeter, Birmingham, Cambridge, and York have received £2.4 million to lead a clinical trial of a home-based cardiac rehabilitation programme for people with heart failure and their caregivers.

Health - Pharmacology - 04.11.2020
Bladder Cancer Research Centre launches at the University of Birmingham
Bladder cancer is relatively common cancer in the UK, with over 10,000 patients diagnosed each year in the UK and approximately 40-50,000 patients living with the disease at any one time.

Health - Pharmacology - 04.11.2020

Health - Pharmacology - 03.11.2020
Lack of understanding of common heart condition leads to missed treatment opportunities
Poor awareness of a condition known as Heart Failure with preserved Ejection Fraction (HFpEF) - the cause of a half of all cases of heart failure in England - could be hindering opportunities to improve care for patients, say researchers from the Universities of Cambridge, Manchester, and Keele. We heard some clinicians asking: what's the point of diagnosis if there is no specific treatment? Christi Deaton HFpEF - pronounced 'heff peff' - is a condition whereby heart muscles are too stiff, preventing the organ's chambers from filling properly with blood.

Pharmacology - Health - 26.10.2020
Cancer anti-sickness drug offers hope for hallucinations in Parkinson’s
A world-first double-blind clinical trial led by UCL researchers will investigate if a powerful drug used to treat nausea in chemotherapy patients could alleviate hallucinations in people with Parkinson's.

Health - Pharmacology - 26.10.2020
What’s the STORY of infectious diseases in the UK?
A study looking at how children's immune systems respond to COVID-19, and to vaccines for other infectious diseases, is asking children under the age of 20 who live in the Bristol area to consider taking part. The research project is being run by the Bristol Children's Vaccine Centre (BCVC) at Bristol Medical School, and the Oxford Vaccine Group which is part of the University of Oxford.

Pharmacology - Health - 26.10.2020
Trial will test existing drugs against rare blood cancer
A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at the Universities of Birmingham and Warwick.

Health - Pharmacology - 15.10.2020
UCL academics named as Future Leaders Fellows
Seven UCL academics have been awarded UKRI Future Leaders fellowships, and will receive government investment to support their research.

Health - Pharmacology - 08.10.2020
Role-playing computer game helps players understand how vaccines work on a global scale
A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.

Health - Pharmacology - 08.10.2020

Health - Pharmacology - 01.10.2020
Opinion: Coronavirus - the three types of vaccine hesitancy authorities need to combat
Honorary Research Associate Annamaria Carusi (UCL Science & Technology Studies) examines the three types of vaccine hesitancy facing authorities' efforts to build public trust in a coronavirus vaccine, including fears over civil liberties, animal welfare and testing.

Health - Pharmacology - 30.09.2020
New trial to treat Covid-19 in care homes using anti-TNF drug begins
Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.

Health - Pharmacology - 30.09.2020
Opinion: Coronavirus - how the pharma industry is changing to produce a vaccine on time
Research Fellow Beatrice Melinek and Dr Stephen Morris (both UCL Biochemical Engineering) write how medical developments accelerate during crises, and share hopes for the production of a successful vaccine for Covid-19. To bring COVID-19 under control a vaccine needs to be available to every nation, rich and poor - and it needs to happen quickly.

Health - Pharmacology - 27.09.2020
Analysis: A million deaths from coronavirus - seven experts consider key questions
Professor Susan Michie (UCL Psychology & Languages Sciences) and Professor Robert West (UCL Epidemiology & Health) join experts in answering questions about the coronavirus, future pandemics and call for "a long-term vision and commitment to have short-term future success.

Life Sciences - Pharmacology - 21.09.2020
Discovery of a druggable pocket in the SARS-CoV-2 Spike protein could stop virus in its tracks
Professor Imre Berger University of Bristol Professor Christiane Schaffitzel University of Bristol 3D structure image of SARS CoV-2 Spike protein University of Bristol 21 September 2020 A druggable pocket in the SARS-CoV-2 Spike protein that could be used to stop the virus from infecting human cells has been discovered by an international team of scientists led by the University of Bristol.

Health - Pharmacology - 16.09.2020
New £4m study to advance our understanding of severe coronavirus infection
The University of Liverpool is leading a major new international project to improve our understanding of severe coronavirus infection in humans, together with collaborators from the University of Oxford, Public Health England, the University of Bristol; A*STAR in Singapore; and King Fahd Medical City in Saudi Arabia.

Health - Pharmacology - 16.09.2020
RECOVERY COVID-19 phase 3 trial to evaluate Regeneron’s REGN-COV2 antibody cocktail
One of the world's largest efforts to find effective COVID-19 treatments will evaluate the impact of REGN-COV2 on mortality, hospital stays, and the need for ventilation. Regeneron Pharmaceuticals, Inc. and the University of Oxford today announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY), one of the world's largest randomised clinical trials of potential COVID-19 treatments, will evaluate Regeneron's investigational anti-viral antibody cocktail, REGN-COV2.

Health - Pharmacology - 11.09.2020
Global consortium launches new study into long-term effects of COVID-19
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), based at Oxford University, in collaboration with Dr Janet Scott, of the MRC-University of Glasgow's Centre for Virus Research, has launched a longitudinal observational study to measure prevalence and risk factors of long-term health and psychosocial consequences of COVID-19.

Health - Pharmacology - 07.09.2020
New global COVID-19 long term study launched
Researchers and clinicians in Glasgow will lead a global study into the long-term health impacts of COVID-19. The international, multi-site study is launched by ISARIC to measure prevalence and risk factors of long-term health and psychosocial consequences of COVID-19. The researchers are inviting hospitals and healthcare sites worldwide to join this new study.

Health - Pharmacology - 03.09.2020

Health - Pharmacology - 28.08.2020
Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus
The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19.

Health - Pharmacology - 28.08.2020
Welsh scientists join UK effort to understand how the immune system responds during Covid-19
Evidence from the pandemic has shown that the immune system can help protect people from Covid-19, but it can also cause damage in severe disease.
1 2 3 4 5 6 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |